Mesoblast Limited (MESO) Stock Analysis

✓ Halal Healthcare
Price $15.20
Market Cap $2.03B

Is MESO a good investment?

Mesoblast Limited (MESO) has a Plutrex AI rating of pending review as of May 26, 2026, indicating a pending review consensus. The stock is halal-compliant per AAOIFI standards.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is MESO a halal stock?

Yes, Mesoblast Limited (MESO) is halal-compliant per AAOIFI standards as of the latest quarterly review.

What is Plutrex's AI rating for MESO?

Mesoblast Limited (MESO) has a Plutrex AI rating of pending review with a pending review consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is MESO a good investment?

According to Plutrex AI, MESO has a pending review rating (pending review). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in MESO?

US stocks like MESO can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in MESO?

Plutrex AI identifies the main risks for MESO by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with Plutrex AI about MESO

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open MESO in Plutrex